Champignon Brands (CSE: SHRM) announced after the bell last night that it intends to change its name, as well as spin out its consumer packaged goods (CPG) division to drive further value for shareholders. Under the proposal, the company will change its name to that of Apotheosis Scientific Ltd.
The justification for Champignon changing its name is that it wishes to have a name that better reflects their business activities. Apotheosis refers to “the highest point in the development of something, culmination or climax.” The term is also used in Greek mythology, referring to “elevation to the status of a god.” Given Champignon’s heavy focus on the scientific aspect of the psychedelics market, the new name is a stronger fit for the firms operations.
In terms of a spin out, Champignon is looking to spin out its CPG division, consisting of its functional mushroom-infused products. The intent is to “liberate the value” of the division, by spinning it out under a plan of arrangement to a separate publicly listed issuer.
An effective date for the spin out has been targeted as being in the third quarter of 2020. The proposed name change has not seen an effective date appointed as of yet.
Champignon Brands last traded at $1.11 on the CSE.
FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.